VVT Med Inc.

Healthcare CA VVTM

0.24CAD
0.00(0%)

Last update at 2026-06-22T13:30:00Z

Day Range

0.240.24

LowHigh

52 Week Range

0.150.75

LowHigh

Fundamentals

Previous Close 0.24
Market Cap15.37M
Volume0
P/E Ratio-
Dividend Yield-%
EBITDA-1.82100M
Revenue TTM0.11M
Revenue Per Share TTM0.02
Gross Profit TTM 0.06M
Diluted EPS TTM-0.06

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2024-12-31	2023-12-31	2022-12-31
Type	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31
Income before tax	-1.04000M	-2.19600M	-2.59400M
Minority interest	-	-	-
Net income	-1.04000M	-2.19600M	-2.59400M
Selling general administrative	1.05M	1.31M	0.92M
Selling and marketing expenses	-	-	-
Gross profit	0.37M	0.00500M	0.00700M
Reconciled depreciation	0.10M	0.09M	0.09M
Ebit	-	-	-
Ebitda	-	-	-
Depreciation and amortization	-	-	-
Non operating income net other	-	-	-
Operating income	-1.09600M	-1.74500M	-2.25100M
Other operating expenses	-	-	-
Interest expense	0.40M	0.35M	0.22M
Tax provision	0.00000M	0.00000M	0.00000M
Interest income	0.00000M	0.00300M	0.00000M
Net interest income	-0.41200M	-0.36000M	-0.23200M
Extraordinary items	-	-	-
Non recurring	-	-	-
Other items	-	-	-
Income tax expense	-	-	-
Total revenue	0.49M	0.04M	0.08M
Total operating expenses	1.59M	1.79M	2.33M
Cost of revenue	0.12M	0.04M	0.07M
Total other income expense net	0.47M	-0.09100M	-0.11100M
Discontinued operations	-	-	-
Net income from continuing ops	-1.04000M	-2.19600M	-2.59400M
Net income applicable to common shares	-	-	-
Preferred stock and other adjustments	-	-	-

Breakdown	2024-12-31	2023-12-31	2022-12-31
Type	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31
Total assets	0.98M	0.89M	0.89M
Intangible assets	-	-	-
Earning assets	-	-	-
Other current assets	-	-	-
Total liab	7.37M	6.25M	4.42M
Total stockholder equity	-6.38000M	-5.35600M	-3.54000M
Deferred long term liab	-	-	-
Other current liab	0.06M	-	-
Common stock	-	-	-
Capital stock	0.02M	0.02M	0.02M
Retained earnings	-20.66200M	-19.62200M	-17.42600M
Other liab	-	-	-
Good will	-	-	-
Other assets	-	-	-
Cash	0.10M	0.07M	0.15M
Cash and equivalents	-	-	-
Total current liabilities	6.71M	4.55M	3.65M
Current deferred revenue	-	-	-
Net debt	5.77M	4.64M	2.75M
Short term debt	-	-	-
Short long term debt	5.50M	3.37M	2.49M
Short long term debt total	-	-	-
Other stockholder equity	-	-	-
Property plant equipment	-	-	-
Total current assets	0.37M	0.34M	0.36M
Long term investments	0.04M	0.04M	0.04M
Net tangible assets	-	-	-
Short term investments	0.00000M	0.01M	-
Net receivables	0.03M	0.03M	0.04M
Long term debt	0.37M	1.34M	0.40M
Inventory	0.22M	0.20M	0.16M
Accounts payable	0.50M	0.58M	0.69M
Total permanent equity	-	-	-
Noncontrolling interest in consolidated entity	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-
Accumulated other comprehensive income	-	-	-
Additional paid in capital	-	-	-
Common stock total equity	-	-	-
Preferred stock total equity	-	-	-
Retained earnings total equity	-	-	-
Treasury stock	-	-	-
Accumulated amortization	-	-	-
Non currrent assets other	-	-	-
Deferred long term asset charges	-	-	-
Non current assets total	0.61M	0.55M	0.52M
Capital lease obligations	0.45M	0.38M	0.46M
Long term debt total	-	-	-

Breakdown	2024-12-31	2023-12-31	2022-12-31
Type	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31
Investments	-	-	-
Change to liabilities	-	-	-
Total cashflows from investing activities	-	-	-
Net borrowings	0.96M	1.42M	1.91M
Total cash from financing activities	0.96M	1.28M	1.86M
Change to operating activities	-	-	-
Net income	-1.04000M	-2.19600M	-2.59400M
Change in cash	0.03M	-0.08000M	-0.06700M
Begin period cash flow	0.07M	0.15M	0.22M
End period cash flow	0.10M	0.07M	0.15M
Total cash from operating activities	-0.91100M	-1.40100M	-1.92900M
Issuance of capital stock	-	-	-
Depreciation	0.10M	0.09M	0.09M
Other cashflows from investing activities	-	-	-
Dividends paid	-	-	-
Change to inventory	-0.02300M	-0.04100M	-0.01200M
Change to account receivables	0.00500M	0.00600M	-0.01200M
Sale purchase of stock	-	-	-
Other cashflows from financing activities	-	-	-
Change to netincome	-	-	-
Capital expenditures	0.00000M	0.00100M	0.02M
Change receivables	-	-	-
Cash flows other operating	-	-	-
Exchange rate changes	-	-	-
Cash and cash equivalents changes	-	-	-
Change in working capital	-0.07200M	0.02M	0.34M
Stock based compensation	0.00000M	0.30M	0.00200M
Other non cash items	0.14M	0.33M	0.23M
Free cash flow	-0.91100M	-1.40200M	-1.94800M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)
VVTM VVT Med Inc.	- -%	0.24	-	-	137.25	-	100.22
TLT Theralase Technologies Inc.	- -%	0.23	-	-	90.07	82.51	90.31	-12.0585
CNVI Conavi Medical Corp.	- -%	0.23	-	-	66.65	-	95.30
PINK Perimeter Medical Imaging AI Inc	-0.005 1.75%	0.28	4.13	-	18.78	11.34	20.22	-2.5521
CHER Cheelcare Inc.	0.10 6.25%	1.70	-	-	20.92	106.42	21.26

Reports Covered

View All

Profile

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P " 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider veins. The company was founded in 2004 and is based in Kfar Saba, Israel.

VVT Med Inc.

Hasadna 6 st., Kfar Saba, Israel, 4442405

972 9 766 0480
https://www.vvtmed.com

Key Executives

Name	Title	Year Born
Mr. Erez Tetro	CEO & Director	NA
Mr. Dor Sneh	CFO & Corporate Secretary	NA
Mr. Gideon Vitkon	Chief of Operations	NA
Orly Efrati	Vice President of Global Marketing	NA
Ms. Orly Efraty	Vice President of Global Marketing	NA
Eyal Alon	Vice President of Global Sales	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.